commercial manufacturing

Lilly focused on 'substantial' increase in manufacturing by 2025

Eli Lilly is planning a "substantial expansion" of its manufacturing capacity for its diabetes meds, relying on internal and external production.

Kevin Dunleavy Dec 6, 2022 8:40am

Yet another Lupin plant in India is in hot water with the FDA

Nov 28, 2022 11:22am

With boost from Romania, Stada breaks ground on $50M plant

Nov 28, 2022 10:05am

Trade groups cry foul to EU's pharma wastewater pay proposal

Nov 10, 2022 9:30am

Pfizer plant workers strike in Australia over pay package

Nov 4, 2022 11:41am

In so many words, FDA admonishes drug manufacturer Nephron

Oct 27, 2022 10:13am